Organic electroluminescent materials and devices

Abstract

A compound having a structure of Formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z, where ligand L.sub.A is ##STR00001##
ligand L.sub.B is ##STR00002##
and ligand L.sub.C is ##STR00003##
is disclosed. In Formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z, M is a metal having an atomic number greater than 40; x is 1, 2, or 3; y and z are 0, 1, or 2; x+y+z is the oxidation state of metal M; Z.sub.1-Z.sub.6 are each C or N; Z.sub.D is N or a carbene carbon; rings C and D are independently a 5 or 6-membered carbocyclic or heterocyclic ring; R.sup.4 is substituted, while each of R.sup.1, R.sup.2, R.sup.3, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are selected from hydrogen and a variety of moieties; and any adjacent substituents of R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are optionally joined to form a ring. Formulations and devices, such as an OLEDs, that include the compound of formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z are also described.

Claims

1. A compound having a structure of formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z: wherein the ligand L.sub.A is ##STR00239## wherein the ligand L.sub.B is ##STR00240## wherein the ligand L.sub.C is ##STR00241## wherein M is a metal having an atomic number greater than 40; wherein x is 1, 2, or 3; wherein y is 0, 1, or 2; wherein z is 0, 1, or 2; wherein x+y+z is the oxidation state of the metal M; wherein Z.sub.1, Z.sub.2, Z.sub.3, Z.sub.4, Z.sub.5, and Z.sub.6 are each independently selected from C and N; wherein Z.sub.D is selected from N and a carbene carbon; wherein rings C and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; wherein R.sup.3 represents mono, or di-substitutions, or no substitutions; wherein R.sup.C, and R.sup.D each independently represent mono, di, tri, or tetra-substitution, or no substitution; wherein R.sup.1 and R.sup.2 each independently represent mono, di, or tri-substitution, or no substitutions; wherein R.sup.4 is selected from the group consisting of halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein each of R.sup.1, R.sup.2, R.sup.3, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any adjacent substituents of R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are optionally joined to form a ring; and wherein at least one of the following: (i) Z.sub.1 is N, (ii) Z.sub.2 is N, (iii) Z.sub.3 is N, (iv) Z.sub.5 is N, (v) R.sub.1 is no substitutions, or (vi) R.sub.1 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, arylalkyl, alkoxy, aryloxy, silyl, alkenyl, cycloalkenyl, alkynyl, aryl, furan, thiophene, acyl, carbonyl, carboxylic acids, ester, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

2. The compound of claim 1, wherein M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu.

3. The compound of claim 1, wherein M is Ir.

4. The compound of claim 1, wherein the compound has the formula M(L.sub.A).sub.2(L.sub.C).

5. The compound of claim 1, wherein the compound has the foil iula M(L.sub.A)(L.sub.B).sub.2.

6. The compound of claim 1, wherein the compound is homoleptic.

7. The compound of claim 1, wherein the aryl or heteroaryl of R.sup.4 is substituted by one or more substituent selected from the group consisting of deuterium, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, cyclobutyl, cyclopentyl, cyclohexyl, and combinations thereof.

8. The compound of claim 1, wherein R.sup.4 is phenyl substituted at both ortho positions by a substituent selected from the group consisting of deuterium, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, cyclobutyl, cyclopentyl, cyclohexyl, and combinations thereof.

9. The compound of claim 1, wherein ligand L.sub.A has the structure: ##STR00242## wherein R.sup.2′ represents mono, or di-substitutions, or no substitutions; wherein R.sup.2′ and R.sup.5 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any adjacent substituents of R.sup.2′, and R.sup.5 are optionally joined to form a ring.

10. The compound of claim 9, wherein R.sup.4 and R.sup.5 are the identical.

11. The compound of claim 1, wherein L.sub.C has the formula: ##STR00243## wherein R.sup.6, R.sup.7, R.sup.8, R.sup.9, and R.sup.10 are independently selected from group consisting of alkyl, cycloalkyl, aryl, and heteroaryl; wherein at least one of R.sup.6, R.sup.7, R.sup.8, R.sup.9, or R.sup.10 has at least two C atoms.

12. The compound of claim 1, wherein ring C is benzene, and ring D is pyridine.

13. The compound of claim 1, wherein L.sub.A is selected from the group consisting of ##STR00244## ##STR00245## ##STR00246## ##STR00247## ##STR00248##

14. The compound of claim 1, wherein L.sub.B is selected from the group consisting of ##STR00249## ##STR00250## ##STR00251## ##STR00252## ##STR00253## ##STR00254## ##STR00255## ##STR00256## ##STR00257## ##STR00258## ##STR00259## ##STR00260## ##STR00261## ##STR00262## wherein X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.1′, X.sup.2′, and X.sup.3′ are each independently selected from the group consisting of N and CR″, wherein each R, R′, and R″ is independently selected from the group consisting of H, alkyl, aryl, heteroaryl, and combinations thereof, and wherein adjacent R, R′, and R″ substituents are optionally joined to form a fused or unfused ring.

15. The compound of claim 1, where L.sub.C is selected from the group consisting of ##STR00263## ##STR00264## ##STR00265##

16. The compound of claim 13, wherein the compound is selected from the group consisting of Compound 1 to Compound 312, where compound x has the formula M(L.sub.Ak).sub.2(L.sub.Cj), wherein x=24j+k−24, wherein k is an integer from 1 to 24, wherein j is an integer from 1 to 13, and wherein L.sub.C is selected from the group consisting of ##STR00266## ##STR00267## ##STR00268##

17. The compound of claim 13, wherein the compound is selected from the group consisting of Compound 313 to Compound 2112, where compound x has the formula M(L.sub.Ak)(L.sub.Bj).sub.2, wherein x=(24j+k−24)+312, wherein k is an integer from 1 to 24, wherein j is an integer from 1 to 75, and wherein L.sub.B is selected from the group consisting of ##STR00269## ##STR00270## ##STR00271## ##STR00272## ##STR00273## ##STR00274## ##STR00275## ##STR00276## ##STR00277## ##STR00278## ##STR00279## ##STR00280## ##STR00281## ##STR00282## wherein X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.1′, X.sup.2′, and X.sup.3′ are each independently selected from the group consisting of N and CR″, wherein each R, R′, and R″ is independently selected from the group consisting of H, alkyl, aryl, heteroaryl, and combinations thereof, and wherein adjacent R, R′, and R″ substituents are optionally joined to form a fused or unfused ring.

18. The compound of claim 1, wherein the compound is selected from the group consisting of ##STR00283## ##STR00284## ##STR00285##

19. A first device comprising one or more organic light emitting devices, at least one of the one or more organic light emitting devices comprising: an anode; a cathode; and an organic layer, disposed between the anode and the cathode, comprising a compound having a formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z: wherein the ligand L.sub.A is ##STR00286## wherein the ligand L.sub.B is ##STR00287## wherein the ligand L.sub.C is ##STR00288## wherein M is a metal having an atomic number greater than 40; wherein x is 1, 2, or 3; wherein y is 0, 1, or 2; wherein z is 0, 1, or 2; wherein x+y+z is the oxidation state of the metal M; wherein Z.sub.1, Z.sub.2, Z.sub.3, Z.sub.4, Z.sub.5, and Z.sub.6 are each independently selected from C and N; wherein Z.sub.D is selected from N and a carbene carbon; wherein rings C and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; wherein R.sup.3 represents mono, or di-substitutions, or no substitutions; wherein R.sup.C, and R.sup.D each independently represent mono, di, tri, or tetra-substitution, or no substitution; wherein R.sup.1 and R.sup.2 each independently represent mono, di, or tri-substitution, or no substitutions; wherein R.sup.4 is selected from the group consisting of halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein each of R.sup.1, R.sup.2, R.sup.3, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any adjacent substituents of R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are optionally joined to form a ring; and wherein at least one of the following: (i) Z.sub.1 is N, (ii) Z.sub.2 is N, (iii) Z.sub.3 is N, (iv) Z.sub.5 is N, (v) R.sub.1 is no substitutions, or (vi) R.sub.1 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, arylalkyl, alkoxy, aryloxy, silyl, alkenyl, cycloalkenyl, alkynyl, aryl, furan, thiophene, acyl, carbonyl, carboxylic acids, ester, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

20. The device of claim 19, wherein the device is selected from the group consisting of a consumer product, an electronic component module, an organic light-emitting device, and a lighting panel.

21. The device of claim 19, wherein the organic layer is an emissive layer and the compound is an emissive dopant or a non-emissive dopant.

22. The device of claim 19, wherein the organic layer further comprises a host, wherein the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan; wherein any substituent in the host is an unfused substituent independently selected from the group consisting of C.sub.nH.sub.2n+1, OC.sub.nH.sub.2n+1, OAr.sub.1, N(C.sub.nH.sub.2n+1).sub.2, N(Ar.sub.1)(Ar.sub.2), CH═CH—C.sub.nH.sub.2n+1, C≡CC.sub.nH.sub.2n+1, Ar.sub.1, Ar.sub.1-Ar.sub.2, and C.sub.nH.sub.2n—Ar.sub.1, or no substitution; wherein n is from 1 to 10; and wherein Ar.sub.1 and Ar.sub.2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof.

23. The device of claim 19, wherein the organic layer further comprises a host, wherein the host comprises at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.

24. The device of claim 19, wherein the organic layer further comprises a host and the host is selected from the group consisting of ##STR00289## ##STR00290## ##STR00291## ##STR00292## ##STR00293## and combinations thereof.

25. The device of claim 19, wherein the organic layer further comprises a host and the host comprises a metal complex.

26. A formulation comprising a compound having a formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z: wherein the ligand L.sub.A is ##STR00294## wherein the ligand L.sub.B is ##STR00295## wherein the ligand L.sub.C is ##STR00296## wherein M is a metal having an atomic number greater than 40; wherein x is 1, 2, or 3; wherein y is 0, 1, or 2; wherein z is 0, 1, or 2; wherein x+y+z is the oxidation state of the metal M; wherein Z.sub.1, Z.sub.2, Z.sub.3, Z.sub.4, Z.sub.5, and Z.sub.6 are each independently selected from C and N; wherein Z.sub.D is selected from N and a carbene carbon; wherein rings C and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; wherein R.sup.3 represents mono, or di-substitutions, or no substitutions; wherein R.sup.C, and R.sup.D each independently represent mono, di, tri, or tetra-substitution, or no substitution; wherein R.sup.1 and R.sup.2 each independently represent mono, di, or tri-substitution, or no substitutions; wherein R.sup.4 is selected from the group consisting of halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein each of R.sup.1, R.sup.2, R.sup.3, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any adjacent substituents of R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are optionally joined to form a ring; and wherein at least one of the following: (i) Z.sub.1 is N, (ii) Z.sub.2 is N, (iii) Z.sub.3 is N, (iv) Z.sub.5 is N, (v) R.sub.1 is no substitutions, or (vi) R.sub.1 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, arylalkyl, alkoxy, aryloxy, silyl, alkenyl, cycloalkenyl, alkynyl, aryl, furan, thiophene, acyl, carbonyl, carboxylic acids, ester, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) FIG. 1 shows an organic light emitting device.

(2) FIG. 2 shows an inverted organic light emitting device that does not have a separate electron transport layer.

(3) FIG. 3 shows the structure of ligand L.sub.A, ligand L.sub.B, and ligand L.sub.C as disclosed herein.

(4) FIG. 4 shows a minimized space filling model of a ligand of Compound A and the chemical structure thereof.

(5) FIG. 5 shows a minimized space filling model of a ligand of Compound E and the chemical structure thereof.

DETAILED DESCRIPTION

(6) Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.

(7) The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.

(8) More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), which are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.

(9) FIG. 1 shows an organic light emitting device 100. The figures are not necessarily drawn to scale. Device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a barrier layer 170. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which are incorporated by reference.

(10) More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F.sub.4-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.

(11) FIG. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has a cathode disposed over the anode, and device 200 has cathode 215 disposed under anode 230, device 200 may be referred to as an “inverted” OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. FIG. 2 provides one example of how some layers may be omitted from the structure of device 100.

(12) The simple layered structure illustrated in FIGS. 1 and 2 is provided by way of non-limiting example, and it is understood that embodiments of the invention may be used in connection with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be achieved by combining the various layers described in different ways, or layers may be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe various layers as comprising a single material, it is understood that combinations of materials, such as a mixture of host and dopant, or more generally a mixture, may be used. Also, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an “organic layer” disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to FIGS. 1 and 2.

(13) Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in FIGS. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Forrest et al., and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entireties.

(14) Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink-jet and OVJD. Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons is a preferred range. Materials with asymmetric structures may have better solution processability than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.

(15) Devices fabricated in accordance with embodiments of the present invention may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.

(16) Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into a variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices such as discrete light source devices or lighting panels, etc. that can be utilized by the end-user product manufacturers. Such electronic component modules can optionally include the driving electronics and/or power source(s). Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of consumer products that have one or more of the electronic component modules (or units) incorporated therein. Such consumer products would include any kind of products that include one or more light source(s) and/or one or more of some type of visual displays. Some examples of such consumer products include flat panel displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, laser printers, telephones, cell phones, tablets, phablets, personal digital assistants (PDAs), laptop computers, digital cameras, camcorders, viewfinders, micro-displays, 3-D displays, vehicles, a large area wall, theater or stadium screen, or a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present invention, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25 degrees C.), but could be used outside this temperature range, for example, from −40 degree C. to +80 degree C.

(17) The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.

(18) The term “halo,” “halogen,” or “halide” as used herein includes fluorine, chlorine, bromine, and iodine.

(19) The term “alkyl” as used herein contemplates both straight and branched chain alkyl radicals. Preferred alkyl groups are those containing from one to fifteen carbon atoms and includes methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, and the like. Additionally, the alkyl group may be optionally substituted.

(20) The term “cycloalkyl” as used herein contemplates cyclic alkyl radicals. Preferred cycloalkyl groups are those containing 3 to 7 carbon atoms and includes cyclopropyl, cyclopentyl, cyclohexyl, and the like. Additionally, the cycloalkyl group may be optionally substituted.

(21) The term “alkenyl” as used herein contemplates both straight and branched chain alkene radicals. Preferred alkenyl groups are those containing two to fifteen carbon atoms. Additionally, the alkenyl group may be optionally substituted.

(22) The term “alkynyl” as used herein contemplates both straight and branched chain alkyne radicals. Preferred alkynyl groups are those containing two to fifteen carbon atoms. Additionally, the alkynyl group may be optionally substituted.

(23) The terms “aralkyl” or “arylalkyl” as used herein are used interchangeably and contemplate an alkyl group that has as a substituent an aromatic group. Additionally, the aralkyl group may be optionally substituted.

(24) The term “heterocyclic group” as used herein contemplates aromatic and non-aromatic cyclic radicals. Hetero-aromatic cyclic radicals also means heteroaryl. Preferred hetero-non-aromatic cyclic groups are those containing 3 or 7 ring atoms which includes at least one hetero atom, and includes cyclic amines such as morpholino, piperdino, pyrrolidino, and the like, and cyclic ethers, such as tetrahydrofuran, tetrahydropyran, and the like. Additionally, the heterocyclic group may be optionally substituted.

(25) The term “aryl” or “aromatic group” as used herein contemplates single-ring groups and polycyclic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is aromatic, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Additionally, the aryl group may be optionally substituted.

(26) The term “heteroaryl” as used herein contemplates single-ring hetero-aromatic groups that may include from one to three heteroatoms, for example, pyrrole, furan, thiophene, imidazole, oxazole, thiazole, triazole, pyrazole, pyridine, pyrazine and pyrimidine, and the like. The term heteroaryl also includes polycyclic hetero-aromatic systems having two or more rings in which two atoms are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is a heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Additionally, the heteroaryl group may be optionally substituted.

(27) The alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, heterocyclic group, aryl, and heteroaryl may be optionally substituted with one or more substituents selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, cyclic amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

(28) As used herein, “substituted” indicates that a substituent other than H is bonded to the relevant position, such as carbon. Thus, for example, where R.sup.1 is mono-substituted, then one R.sup.1 must be other than H. Similarly, where R.sup.1 is di-substituted, then two of R.sup.1 must be other than H. Similarly, where R.sup.1 is unsubstituted, R.sup.1 is hydrogen for all available positions.

(29) The “aza” designation in the fragments described herein, i.e. aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more of the C—H groups in the respective fragment can be replaced by a nitrogen atom, for example, and without any limitation, azatriphenylene encompasses both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of ordinary skill in the art can readily envision other nitrogen analogs of the aza-derivatives described above, and all such analogs are intended to be encompassed by the terms as set forth herein.

(30) It is to be understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. phenyl, phenylene, naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g. benzene, naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.

(31) According to one embodiment, a compound having a structure of Formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z is disclosed, where ligand L.sub.A is

(32) ##STR00008##
ligand L.sub.B is

(33) ##STR00009##
and ligand L.sub.C is

(34) ##STR00010##
In the structure of Formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z:

(35) M is a metal having an atomic number greater than 40;

(36) x is 1, 2, or 3;

(37) y is 0, 1, or 2;

(38) z is 0, 1, or 2;

(39) x+y+z is the oxidation state of the metal M;

(40) Z.sub.1, Z.sub.2, Z.sub.3, Z.sub.4, Z.sub.5, and Z.sub.6 are each independently selected from C and N;

(41) Z.sub.D is selected from N and a carbene carbon;

(42) rings C and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring;

(43) R.sup.3 represents mono, or di-substitutions, or no substitutions;

(44) R.sup.C, and R.sup.D each independently represent mono, di, tri, or tetra-substitution, or no substitution;

(45) R.sup.1 and R.sup.2 each independently represent mono, di, or tri-substitution, or no substitutions;

(46) R.sup.4 is selected from the group consisting of halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;

(47) each of R.sup.1, R.sup.2, R.sup.3, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and

(48) any adjacent substituents of R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.C, R.sup.D, R.sup.11, R.sup.12, and R.sup.13 are optionally joined to form a ring.

(49) In some embodiments, at least one of Z.sub.1, Z.sub.2, Z.sub.3, Z.sub.4, Z.sub.5, and Z.sub.6 is N, while exactly one of Z.sub.1, Z.sub.2, Z.sub.3, Z.sub.4, Z.sub.5, and Z.sub.6 is N in other embodiments. In some embodiments, Z.sub.3, Z.sub.6, or both are N. In some embodiments, Z.sub.1, Z.sub.2, Z.sub.3, Z.sub.4, Z.sub.5, and Z.sub.6 are each C.

(50) In some embodiments, M is a metal selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu. In some embodiments. M is Ir.

(51) In some embodiments, the compound is homoleptic, while the compound is heteroleptic in other embodiments. In some embodiments, the compound has the formula M(L.sub.A).sub.2(L.sub.C). In some embodiments, the compound is selected from Compound 1 to Compound 312, where compound x has the formula M(L.sub.Ak).sub.2(L.sub.Cj), wherein x=24j+k−24, where k is an integer from 1 to 24, and j is an integer from 1 to 13.

(52) In some embodiments, the compound has the formula M(L.sub.A)(L.sub.B).sub.2. In some embodiments, the compound is selected from Compound 313 to Compound 2112, where compound x has the formula M(L.sub.Ak)(L.sub.Bj).sub.2, wherein x=(24j+k−24)+312, where k is an integer from 1 to 24, and j is an integer from 1 to 75.

(53) In some embodiments, the aryl or heteroaryl of R.sup.4 is substituted by one or more substituent selected from the group consisting of deuterium, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, cyclobutyl, cyclopentyl, cyclohexyl, and combinations thereof. In some embodiments, R.sup.4 is phenyl substituted at both ortho positions by a substituent selected from the group consisting of deuterium, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, cyclobutyl, cyclopentyl, cyclohexyl, and combinations thereof. In some embodiments, R.sup.4 is phenyl substituted by an identical substituent at both ortho positions.

(54) In some embodiments, ligand L.sub.A has the structure

(55) ##STR00011##
where:

(56) R.sup.2′ represents mono, or di-substitutions, or no substitutions;

(57) R.sup.2′ and R.sup.5 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and

(58) any adjacent substituents of R.sup.2′, and R.sup.5 are optionally joined to form a ring.

(59) In some embodiments, R.sup.4 and R.sup.5 are identical.

(60) In some embodiments, ligand L.sub.C has the formula

(61) ##STR00012##
where:

(62) R.sup.6, R.sup.7, R.sup.8, R.sup.9, and R.sup.10 are independently selected from group consisting of alkyl, cycloalkyl, aryl, and heteroaryl; and

(63) at least one of R.sup.6, R.sup.7, R.sup.8, R.sup.9, and R.sup.10 has at least two C atoms.

(64) In some embodiments, ligand L.sub.A is selected from the group consisting of:

(65) ##STR00013## ##STR00014## ##STR00015## ##STR00016## ##STR00017##

(66) In some embodiments, ring C is benzene, and ring D is pyridine. In some embodiments, ligand L.sub.B is selected from the group consisting of:

(67) ##STR00018## ##STR00019## ##STR00020## ##STR00021## ##STR00022## ##STR00023## ##STR00024## ##STR00025## ##STR00026## ##STR00027## ##STR00028## ##STR00029## ##STR00030## ##STR00031##

(68) wherein X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.1′, X.sup.2′, and X.sup.3′ are each independently selected from the group consisting of N and CR″,

(69) wherein each R, R′, and R″ is independently selected from the group consisting of H, alkyl, aryl, heteroaryl, and combinations thereof, and

(70) wherein adjacent R, R′, and R″ substituents are optionally joined to form a fused or unfused ring.

(71) In some embodiments, ligand L.sub.B is phenyl-pyridine based ligand selected from L.sub.B1 through L.sub.B41. In some embodiments, ligand L.sub.B is coordinated to metal M by a carbene carbon and is selected from L.sub.B42-L.sub.B66. Ligand L.sub.B can also be selected from L.sub.B67-L.sub.B75.

(72) In some embodiments, ligand L.sub.C is selected from the group consisting of:

(73) ##STR00032## ##STR00033## ##STR00034##

(74) In some embodiments, the compound is selected from the group consisting of:

(75) ##STR00035## ##STR00036## ##STR00037##

(76) In some embodiments, the compound can be an emissive dopant. In some embodiments, the compound can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.

(77) According to another aspect of the present disclosure, a device that includes one or more organic light emitting devices is also provided. At least one of the one or more organic light emitting devices can include an anode, a cathode, and an organic layer disposed between the anode and the cathode. The organic layer may include a host and a phosphorescent dopant. The emissive layer can include a compound according to Formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z, and its variations as described herein.

(78) The device can be one or more of a consumer product, an electronic component module, an organic light-emitting device and a lighting panel. The organic layer can be an emissive layer and the compound can be an emissive dopant in some embodiments, while the compound can be a non-emissive dopant in other embodiments.

(79) The organic layer can also include a host. In some embodiments, the host can include a metal complex. The host can be a triphenylene containing benzo-fused thiophene or benzo-fused furan. Any substituent in the host can be an unfused substituent independently selected from the group consisting of C.sub.nH.sub.2n+1, OC.sub.nH.sub.2n+1, OAr.sub.1, N(C.sub.nH.sub.2n+1).sub.2, N(Ar.sub.1)(Ar.sub.2), CH═CH—C.sub.nH.sub.2n+1, C≡C—C.sub.nH.sub.2n+1, Ar.sub.1, Ar.sub.1-Ar.sub.2, and C.sub.nH.sub.2n—Ar.sub.1, or no substitution. In the preceding substituents n can range from 1 to 10; and Ar.sub.1 and Ar.sub.2 can be independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof.

(80) The host can be a compound comprising at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene. The host can include a metal complex. The host can be a specific compound selected from the group consisting of:

(81) ##STR00038## ##STR00039## ##STR00040## ##STR00041## ##STR00042##
and combinations thereof.

(82) In yet another aspect of the present disclosure, a formulation that comprises a compound according to Formula M(L.sub.A).sub.x(L.sub.B).sub.y(L.sub.C).sub.z is described. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, and an electron transport layer material, disclosed herein.

(83) Combination with Other Materials

(84) The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.

(85) HIL/HTL:

(86) A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoO.sub.x; a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compound.

(87) Examples of aromatic amine derivatives used in HIL or HTL include, but are not limited to the following general structures:

(88) ##STR00043##

(89) Each of Ar.sup.1 to Ar.sup.9 is selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Wherein each Ar is further substituted by a substituent selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

(90) In one aspect, Ar.sup.1 to Ar.sup.9 is independently selected from the group consisting of:

(91) ##STR00044##
wherein k is an integer from 1 to 20; X.sup.101 to X.sup.108 is C (including CH) or N; Z.sup.101 is NAr.sup.1, O, or S; Ar.sup.1 has the same group defined above.

(92) Examples of metal complexes used in HIL or HTL include, but are not limited to the following general formula:

(93) ##STR00045##
wherein Met is a metal, which can have an atomic weight greater than 40; (Y.sup.101-Y.sup.102) is a bidentate ligand, Y.sup.101 and Y.sup.102 are independently selected from C, N, O, P, and S; L.sup.101 is an ancillary ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

(94) In one aspect, (Y.sup.101-Y.sup.102) is a 2-phenylpyridine derivative. In another aspect, (Y.sup.101-Y.sup.102) is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os, and Zn. In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc.sup.+/Fc couple less than about 0.6 V.

(95) Host:

(96) The light emitting layer of the organic EL device of the present invention preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. While the Table below categorizes host materials as preferred for devices that emit various colors, any host material may be used with any dopant so long as the triplet criteria is satisfied.

(97) Examples of metal complexes used as host are preferred to have the following general formula:

(98) ##STR00046##
wherein Met is a metal; (Y.sup.103-Y.sup.104) is a bidentate ligand, Y.sup.103 and Y.sup.104 are independently selected from C, N, O, P, and S; L.sup.101 is an another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

(99) In one aspect, the metal complexes are:

(100) ##STR00047##
wherein (O—N) is a bidentate ligand, having metal coordinated to atoms O and N.

(101) In another aspect, Met is selected from Ir and Pt. In a further aspect, (Y.sup.103-Y.sup.104) is a carbene ligand.

(102) Examples of organic compounds used as host are selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Wherein each group is further substituted by a substituent selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

(103) In one aspect, the host compound contains at least one of the following groups in the molecule:

(104) ##STR00048## ##STR00049##
wherein R.sup.101 to R.sup.107 is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. k is an integer from 0 to 20 or 1 to 20; k′″ is an integer from 0 to 20. X.sup.101 to X.sup.108 is selected from C (including CH) or N. Z.sup.101 and Z.sup.102 is selected from NR.sup.101, O, or S.
HBL:

(105) A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED.

(106) In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.

(107) In another aspect, compound used in HBL contains at least one of the following groups in the molecule:

(108) ##STR00050##
wherein k is an integer from 1 to 20; L.sup.101 is an another ligand, k′ is an integer from 1 to 3.
ETL:

(109) Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.

(110) In one aspect, compound used in ETL contains at least one of the following groups in the molecule:

(111) ##STR00051##
wherein R.sup.101 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. Ar.sup.1 to Ar.sup.3 has the similar definition as Ar's mentioned above. k is an integer from 1 to 20. X.sup.101 to X.sup.108 is selected from C (including CH) or N.

(112) In another aspect, the metal complexes used in ETL include, but are not limited to the following general formula:

(113) ##STR00052##
wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L.sup.101 is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.

(114) In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. encompasses undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also encompass undeuterated, partially deuterated, and fully deuterated versions thereof.

(115) In addition to and/or in combination with the materials disclosed herein, many hole injection materials, hole transporting materials, host materials, dopant materials, exciton/hole blocking layer materials, electron transporting and electron injecting materials may be used in an OLED. Non-limiting examples of the materials that may be used in an OLED in combination with materials disclosed herein are listed in Table A below. Table A lists non-limiting classes of materials, non-limiting examples of compounds for each class, and references that disclose the materials.

(116) TABLE-US-00001 TABLE A MATERIAL EXAMPLES OF MATERIAL PUBLICATIONS Hole injection materials Phthalocyanine and porphyrin compounds Appl. Phys. Lett. 69, 2160 (1996) Starburst triarylamines J. Lumin. 72-74, 985 (1997) CF.sub.x Fluorohydrocarbon polymer Appl. Phys. Lett. 78, 673 (2001) Conducting polymers (e.g., PEDOT:PSS, polyaniline, polythiophene) Synth. Met. 87, 171 (1997) WO2007002683 Phosphonic acid and silane SAMs US20030162053 Triarylamine or polythiophene polymers with conductivity dopants EP1725079A1 0 Organic compounds with conductive inorganic compounds, such as molybdenum and tungsten oxides US20050123751 SID Symposium Digest, 37, 923 (2006) WO2009018009 n-type semiconducting organic complexes US20020158242 Metal organometallic complexes US20060240279 Cross-linkable compounds US20080220265 Polythiophene based polymers and copolymers WO 2011075644 EP2350216 Hole transporting materials Triarylamines (e.g., TPD, α-NPD) Appl. Phys. Lett. 51, 913 (1987) U.S. Pat. No. 5,061,569 EP650955 J. Mater. Chem. 3, 319 (1993) 0 Appl. Phys. Lett. 90, 183503 (2007) Appl. Phys. Lett. 90, 183503 (2007) Triarylamine on spirofluorene core Synth. Met. 91, 209 (1997) Arylamine carbazole compounds Adv. Mater. 6, 677 (1994), US20080124572 Triarylamine with (di)benzothiophene/ (di)benzofuran US20070278938, US20080106190 US20110163302 Indolocarbazoles Synth. Met. 111, 421 (2000) Isoindole compounds Chem. Mater. 15, 3148 (2003) Metal carbene complexes US20080018221 Phosphorescent OLED host materials Red hosts Arylcarbazoles Appl. Phys. Lett. 78, 1622 (2001) Metal 8- hydroxyquinolates (e.g., Alq.sub.3, Balq) Nature 395, 151 (1998) 0 US20060202194 WO2005014551 WO2006072002 Metal phenoxybenzothiazole compounds Appl. Phys. Lett. 90, 123509 (2007) Conjugated oligomers and polymers (e.g., polyfluorene) Org. Electron. 1, 15 (2000) Aromatic fused rings WO2009066779, WO2009066778, WO2009063833, US20090045731, US20090045730, WO2009008311, US20090008605, US20090009065 Zinc complexes WO2010056066 Chrysene based compounds WO2011086863 Green hosts Arylcarbazoles Appl. Phys. Lett. 78, 1622 (2001) US20030175553 0 WO2001039234 Aryltriphenylene compounds US20060280965 US20060280965 WO2009021126 Poly-fused heteroaryl compounds US20090309488 US20090302743 US20100012931 Donor acceptor type molecules WO2008056746 WO2010107244 Aza-carbazole/ DBT/DBF JP2008074939 US20100187984 Polymers (e.g., PVK) Appl. Phys. Lett. 77, 2280 (2000) Spirofluorene compounds 00 WO2004093207 Metal phenoxybenzooxazole compounds 01 WO2005089025 02 WO2006132173 03 JP200511610 Spirofluorene- carbazole compounds 04 JP2007254297 05 JP2007254297 Indolocarbazoles 06 WO2007063796 07 WO2007063754 5-member ring electron deficient heterocycles (e.g., triazole, oxadiazole) 08 J. Appl. Phys. 90, 5048 (2001) 09 WO2004107822 Tetraphenylene complexes 0 US20050112407 Metal phenoxypyridine compounds WO2005030900 Metal coordination complexes (e.g., Zn, Al with N{circumflex over ( )}N ligands) US20040137268, US20040137267 Blue hosts Arylcarbazoles Appl. Phys. Lett, 82, 2422 (2003) US20070190359 Dibenzothiophene/ Dibenzofuran-carbazole compounds WO2006114966, US20090167162 US20090167162 WO2009086028 US20090030202, US20090017330 US20100084966 Silicon aryl compounds 0 US20050238919 WO2009003898 Silicon/Germanium aryl compounds EP2034538A Aryl benzoyl ester WO2006100298 Carbazole linked by non-conjugated groups US20040115476 Aza-carbazoles US20060121308 High triplet metal organometallic complex U.S. Pat. No. 7,154,114 Phosphorescent dopants Red dopants Heavy metal porphyrins (e.g., PtOEP) Nature 395, 151 (1998) Iridium(III) organometallic complexes Appl. Phys. Lett. 78, 1622 (2001) US20030072964 0 US20030072964 US20060202194 US20060202194 US20070087321 US20080261076 US20100090591 US20070087321 Adv. Mater. 19, 739 (2007) WO2009100991 WO2008101842 U.S. Pat. No. 7,232,618 Platinum(II) organometallic complexes 0 WO2003040257 US20070103060 Osmium(III) complexes Chem. Mater. 17, 3532 (2005) Ruthenium(II) complexes Adv. Mater. 17, 1059 (2005) Rhenium (I), (II), and (III) complexes US20050244673 Green dopants Iridium(III) organometallic complexes Inorg. Chem. 40, 1704 (2001) US20020034656 U.S. Pat. No. 7,332,232 US20090108737 WO2010028151 0 EP1841834B US20060127696 US20090039776 U.S. Pat. No. 6,921,915 US20100244004 U.S. Pat. No. 6,687,266 Chem. Mater. 16, 2480 (2004) US20070190359 US 20060008670 JP2007123392 WO2010086089, WO2011044988 0 Adv. Mater. 16, 2003 (2004) Angew. Chem. Int. Ed. 2006, 45, 7800 WO2009050290 US20090165846 US20080015355 US20010015432 US20100295032 Monomer for polymeric metal organometallic compounds U.S. Pat. No. 7,250,226, U.S. Pat. No. 7,396,598 Pt(II) organometallic complexes, including polydentate ligands Appl. Phys. Lett. 86, 153505 (2005) Appl. Phys. Lett. 86, 153505 (2005) 0 Chem. Lett. 34, 592 (2005) WO2002015645 US20060263635 US20060182992 US20070103060 Cu complexes WO2009000673 US20070111026 Gold complexes Chem. Commun. 2906 (2005) Rhenium(III) complexes Inorg. Chem. 42, 1248 (2003) Osmium(II) complexes U.S. Pat. No. 7,279,704 Deuterated organometallic complexes US20030138657 Organometallic complexes with two or more metal centers 0 US20030152802 U.S. Pat. No. 7,090,928 Blue dopants Iridium(III) organometallic complexes WO2002002714 WO2006009024 US20060251923 US20110057559 US20110204333 U.S. Pat. No. 7,393,599, WO2006056418, US20050260441, WO2005019373 U.S. Pat. No. 7,534,505 WO2011051404 U.S. Pat. No. 7,445,855 US20070190359, US20080297033 US20100148663 0 U.S. Pat. No. 7,338,722 US20020134984 Angew. Chem. Int. Ed. 47, 4542 (2008) Chem. Mater. 18, 5119 (2006) Inorg. Chem. 46, 4308 (2007) WO2005123873 WO2005123873 WO2007004380 WO2006082742 Osmium(II) complexes U.S. Pat. No. 7,279,704 00 Organometallics 23, 3745 (2004) Gold complexes 01 Appl. Phys. Lett. 74, 1361 (1999) Platinum(II) complexes 02 WO2006098120, WO2006103874 Pt tetradentate complexes with at least one metal- carbene bond 03 U.S. Pat. No. 7,655,323 Exciton/hole blocking layer materials Bathocuproine compounds (e.g., BCP, BPhen) 04 Appl. Phys. Lett. 75, 4 (1999) 05 Appl. Phys. Lett. 79, 449 (2001) Metal 8- hydroxyquinolates (e.g., BAlq) 06 Appl. Phys. Lett. 81, 162 (2002) 5-member ring electron deficient heterocycles such as triazole, oxadiazole, imidazole, benzoimidazole 07 Appl. Phys. Lett. 81, 162 (2002) Triphenylene compounds 08 US20050025993 Fluorinated aromatic compounds 09 Appl. Phys. Lett. 79, 156 (2001) Phenothiazine-S-oxide 0 WO2008132085 Silylated five- membered nitrogen, oxygen, sulfur or phosphorus dibenzoheterocycles WO2010079051 Aza-carbazoles US20060121308 Electron transporting materials Anthracene- benzoimidazole compounds WO2003060956 US20090179554 Aza triphenylene derivatives US20090115316 Anthracene- benzothiazole compounds Appl. Phys. Lett. 89, 063504 (2006) Metal 8- hydroxyquinolates (e.g., Alq.sub.3, Zrq.sub.4) Appl. Phys. Lett. 51, 913 (1987) U.S. Pat. No. 7,230,107 Metal hydroxy- benzoquinolates Chem. Lett. 5, 905 (1993) Bathocuproine compounds such as BCP, BPhen, etc Appl. Phys. Lett. 91, 263503 (2007) 0 Appl. Phys. Lett. 79, 449 (2001) 5-member ring electron deficient heterocycles (e.g., triazole, oxadiazole, imidazole, benzoimidazole) Appl. Phys. Lett. 74, 865 (1999) Appl. Phys. Lett. 55, 1489 (1989) Jpn. J. Apply. Phys. 32, L917 (1993) Silole compounds Org. Electron. 4, 113 (2003) Arylborane compounds J. Am. Chem. Soc. 120, 9714 (1998) Fluorinated aromatic compounds J. Am. Chem. Soc. 122, 1832 (2000) Fullerene (e.g., C60) US20090101870 Triazine complexes US20040036077 Zn (N{circumflex over ( )}N) complexes U.S. Pat. No. 6,528,187

EXPERIMENTAL

Synthetic Examples

(117) All reagents were purchased from Aldrich with the exception of Tetrakis(triphenylphosphene) palladium (0), which was purchased from Strem, and 2-bromonicotinic acid, which was purchased from Matrix Scientific.

(118) The following is a schematic of the synthesis of meridonal tris(12-methylbenzo[f][1,7]phenanthroline) iridium (III)(Compound D), starting with 2-bromo-N,N-diethylnicotinamide.

(119) ##STR00230##
Additional details of each step can be found in the step-by-step explanations below.

Synthesis of 2-bromo-N,N-diethylnicotinamide

(120) A 500 mL three neck flask was charged with 27.4 g of 2-bromonicotinic acid and 100 mL of SOCl.sub.2. The mixture was refluxed for 2 hours and the red-orange solution was cooled to ambient temperature (e.g., 25° C.). Excess SOCl.sub.2 was removed by vacuum distillation, then rinsed 3 times with anhydrous toluene. The resulting solid acid chloride was suspended in 300 mL anhydrous dichloromethane, cooled over an ice bath, and treated with 40 mL diethylamine added in one portion. The solution was then stirred at room temperature overnight (e.g., 16 hours), then washed successively with aqueous sodium bicarbonate and aqueous ammonium chloride. The organic phase was then dried over sodium sulfate and evaporated in vacuo to yield 2-bromo-N,N-diethylnicotinamide as a light brown oil (29.2 g. 84%).

Synthesis of 2-(2,6-dimethylphenyl)-N,N-diethylnicotinamide

(121) A 250 mL round bottom flask fitted with a reflux condenser was charged with 8.5 g of 2-bromo-N,N-diethylnicotinamide, 5.3 g (1.1 eq) of 2,6-dimethylphenylboronic acid, 100 mL of 1,4 dioxane, and 50 mL of 2M aqueous potassium carbonate. The biphasic mixture was sparged with nitrogen with vigorous magnetic stirring. After 10 minutes, 1.4 g of tetrakis(triphenylphosphene) palladium (0) was added and the mixture was sparged with nitrogen for a further 10 minutes. The reaction was held at 90° C. for 20 hours, cooled, then diluted with 200 mL of ethyl acetate. The organic phase is washed with water (100 mL), then brine (100 mL), before being dried over sodium sulfate. The organic phase was concentrated to a viscous amber oil, which was chromatographed over silica with an ethyl acetate:hexanes (1:1) mixture to give a yellow solid. Recrystallization in diethyl ether layered with hexanes yielded colorless prisms of 2-(2,6-dimethylphenyl)-N,N-diethylnicotinamide (3.6 g, 38% yield).

Synthesis of 10-methylbenzo[h]quinolin-5-ol

(122) A flame dried 250 mL schlenk flask was charged with 2.2 g of 2-(2,6-dimethylphenyl)-N,N-diethylnicotinamide and 100 mL of anhydrous tetrahydrofuran (THF). The solution was cooled to −78° C. under a nitrogen atmosphere with magnetic stirring. A 2 M solution of lithium diisopropylamide (LDA) (5 mL, 10 mMol) was added dropwise and the reaction was allowed to warm to room temperature overnight. Saturated aqueous ammonium chloride (50 mL) was added and the volume was reduced under reduced pressure. Dichloromethane (100 mL) was added and the organic phase was washed with water (100 mL), then brine (100 mL), before being dried over sodium sulfate. The organic phase was concentrated to a dark brown oil which was chromatographed over silica with a ethyl acetate:hexanes (1:3) solution to give 10-methylbenzo[h]quinolin-5-ol as a colorless solid (1.29 g, 79%).

Synthesis of 10-methylbenzo[h]quinoline-5,6-dione

(123) A 1 L beaker was charged with 1.29 g of 10-methylbenzo[h]quinolin-5-ol, 100 mL of dichloromethane, 200 mL of acetone, and 300 mL of saturated aqueous sodium bicarbonate. The colorless biphasic mixture was stirred vigorously and 10 g of oxone monopersulfate (KHSO.sub.5.0.5 KHSO.sub.4.0.5K2SO.sub.4) was added in 10 portions with care to avoid excessive foaming. After 1 hour the bright yellow organic phase was separated, washed with brine (100 mL), and concentrated in vacuo to give a yellow solid. Recrystallization from hot ethanol yielded orange needle-like prisms of 10-methylbenzo[h]quinoline-5,6-dione (835 mg, 61%).

Synthesis of 9-methylbenzo[h][1,2,4]triazino[5,6-f]quinoline

(124) A 250 mL schlenk flask was charged with 756 mg of 10-methylbenzo[h]quinoline-5,6-dione and 200 mL of anhydrous methanol. A formamidrazone solution freshly prepared by adding 240 uL anhydrous hydrazine to 800 mg formamidine acetate in 15 mL dry methanol was then added to the solution. The suspension was stirred magnetically at room temperature under nitrogen atmosphere for 16 hours, after which the pale orange precipitate was collected by filtration and washed with 20 mL of ethanol. The solid powder was allowed to air dry yielding 9-methylbenzo[h][1,2,4]triazino[5,6-f]quinoline and 8-methylbenzo[h][1,2,4]triazino[5,6-f]quinoline as a 3:2 mixture which was used without separation (516 mg, 62%).

Synthesis of 12-methylbenzo[f][1,7]phenanthroline, (BzpH)

(125) A 100 mL schlenk flask fitted with a reflux condenser was charged with 2 mL of norbonadiene, 25 mL of triethylene glycol, and 516 mg of a 3:2 mixture of 9-methylbenzo[h][1,2,4]triazino[5,6-f]quinoline and 8-methylbenzo[h][1,2,4]triazino[5,6-f]quinoline. The reaction mixture was sparged with nitrogen for 10 minutes and then heated to 170° C. for 16 hours. The reaction was cooled to room temperature, diluted with dichloromethane (100 mL) and washed with water (5×50 mL). The organic phase was dried over sodium sulfate and then dried in vacuo. The pale yellow residue was chromatographed twice over silica with 15% ethylacetate in hexanes, first eluting 9-methylbenzo[f][4,7]phenanthroline (iso-BzpH), and then 12-methylbenzo[f][1,7]phenanthroline (BzpH), which crystallized as colorless plates by slow evaporation of tetrahydrofuran (THF) (150 mg, 49%).

Synthesis of Meridonal tris(12-methylbenzo[f][1,7]phenanthroline) iridium (III), (Mer-Ir(Bzp)3)(Compound D)

(126) A 15 mL Schlenk tube fitted with a reflux condenser was charged with 80 mg of BzpH, 20 mg of tris(acetylacetonato)iridium (III), and 4 mL of glycerol. The reaction mixture was deoxygenated by 3 cycles of vacuum (15 minutes) and nitrogen refill. The reaction mixture was placed in a sand bath and heated under nitrogen to vigorous reflux (ca. 350° C.) for 16 hours. The dark brown solution was allowed to cool to ambient temperature, diluted with 100 mL of water, then 25 mL of brine, and extracted with dichloromethane (100 mL). The organic phase was dried in vacuo and chromatographed over silica with an ethyl acetate:hexanes (1:1) solution to yield mer-Ir(Bzp).sub.3 as a yellow solid (10 mg, 27%).

Synthetic Route for Compound A

(127) An analogous synthetic route for producing Compound A is provided below.

(128) ##STR00231##

(129) Proposed Synthetic Route for Compound 9

(130) ##STR00232##

(131) Proposed Synthesis of tetrakis(12-phenylbenzo[f][1,7]phenanthroline)-u-dichloro diiridium (III)

(132) A schlenk flask fitted with a reflux condenser can be charged with 2 equivalents of 12-phenylbenzo[f][1,7]phenanthroline, 1 equivalent of iridium trichloride hexahydrate, ethoxyethanol, and water. The mixture can be sparged with nitrogen and then heated to reflux under nitrogen atmosphere (ca. 140 C). After 16 hours the reaction would be cooled to room temperature and diluted with water. The precipitate would then be collected by filtration and washed with methanol.

Proposed Synthesis of bis(12-phenylbenzo[f][1,7]phenanthroline) acetoacetonato iridium (III), (compound 9)

(133) A round bottom flask can be charged with 1 equivalent of tetrakis(12-phenylbenzo[f][1,7]phenanthroline)-u-dichloro diiridium (III), 3 equivalents of 2,4-pentanedione, 3 equivalents of potassium carbonate, and 1,2-dichloroethane. The reaction would then be sparged with nitrogen and heated to reflux (ca. 90 C) for 3 hours. The reaction could then be cooled, the solvent evaporated to dryness, and the residue chromatographed on silica to isolate bis(12-phenylbenzo[f][1,7]phenanthroline) acetoacetonato iridium (III) (Compound 9).

(134) Analysis of Compounds

(135) As can be seen in the space filling model, calculated by density functional theory (DFT), and shown in FIG. 4, the aryl substituent sterically shields the uncoordinated nitrogen from close contact of a neighboring intra or intermolecular proton atom. As shown in FIG. 5, the space filling model of Compound E shows close contact of an intramolecular proton from the neighboring methyl substituent. In contrast, the unsubstituted Comparative Example 1 has an unprotected nitrogen that will be more susceptible to being protonated by any neighboring molecule in the solid state.

(136) Furthermore, as the aryl substitution necessarily twists out of the plane of the ligand, there is a minimal effect on the triplet energy of the complex. DFT calculations are shown in Table 1 below. DFT calculations were performed using the B3LYP/cep-31 g/THF functional, basis set, and solvent polarization, respectively. It can be seen that Compound A has a calculated triplet of 488 nm compared to 490 nm for Compound E, and 482 nm for Comparative Example 1.

(137) TABLE-US-00002 TABLE 1 HOMO LUMO Gap Dipole S1.sub.THF T1.sub.THF Structure (eV) (ev) (ev) (Debye) (nm) (nm) Comparative Example 1 −5.83 −1.99 −3.85 15.00 420 482 Compound A −5.79 −1.99 −3.80 15.40 427 488 Compound B −5.76 −1.96 −3.81 15.60 428 503 Compound C −5.75 −1.94 −3.82 15.66 424 491 Compound D −5.75 −1.96 −3.79 13.43 430 487 Compound E −5.70 −1.89 −3.80 14.20 427 490

(138) It is understood that the various embodiments described herein are by way of example only, and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting.